<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2628">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04334148</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00105274</org_study_id>
    <nct_id>NCT04334148</nct_id>
  </id_info>
  <brief_title>Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine</brief_title>
  <acronym>HERO-HCQ</acronym>
  <official_title>Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine Trial (HERO-HCQ Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Adrian Hernandez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double blind, placebo controlled study in approximately 2,000 health care workers
      at risk for being exposed to COVID-19. Eligible participants will be randomly assigned (1:1)
      to either treatment group (HCQ) or placebo in a double-blind fashion. Course of treatment is
      30 days.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a double blind, placebo controlled study in approximately 2,000 health care workers
      at risk for being exposed to COVID-19. Eligible participants will be randomly assigned (1:1)
      to either treatment group (HCQ) or placebo in a double-blind fashion. After enrollment,
      baseline assessments will include nasopharyngeal swab for COVID-19 and a blood sample to
      detect seroconversion to COVID-19. For convenience, follow-up will be performed weekly
      through a direct to participant portal. A call center will provide support for any missed
      visits. Follow-up includes screening for any COVID-19 clinical infections, other respiratory
      infections, clinical events, adverse events, and Quality of Life (QoL) assessments. Course of
      treatment is 30 days. Participants are followed via survey weekly. At the end of treatment
      participants will return for repeat nasopharyngeal swab for COVID-19 and a blood sample to
      detect seroconversion to COVID-19. There will be one last contact at 8 weeks (2 months) from
      baseline.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 22, 2020</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Double blind, placebo-controlled, randomized clinical trial.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Double-blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with clinical infection with COVID-19 infection</measure>
    <time_frame>30 days</time_frame>
    <description>Number of participants with clinical infection with COVID-19 infection(hydroxychloroquine vs placebo)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with COVID-19 viral shedding</measure>
    <time_frame>30 days</time_frame>
    <description>Number of participants with COVID-19 infection shedding (hydroxychloroquine vs placebo)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety as measured by number of adverse events</measure>
    <time_frame>30 days</time_frame>
    <description>Safety as measured by number of adverse events (hydroxychloroquine vs placebo)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Hydroxychloroquine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hydroxychloroquine tablet 600mg bid loading dose on day 1 followed by 400mg on days 2-30.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo tablets</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxychloroquine</intervention_name>
    <description>oral self administered tablet</description>
    <arm_group_label>Hydroxychloroquine</arm_group_label>
    <other_name>Plaquenil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo oral tablet</intervention_name>
    <description>oral self administered tablet</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion:

          -  Completed Informed Consent

          -  Age ≥ 18 years old

          -  Currently working in any environment in which there is a risk of exposure to patients
             with COVID-19 infections (&quot;healthcare worker&quot;)

        Exclusion Criteria:

          -  Prior diagnosis of COVID-19 infection

          -  Participation in another COVID-19 prophylaxis trial within 30 days of consent

          -  Respiratory illness with new-onset fever (Temperature &gt; 100°F) or ongoing cough or
             dyspnea within 14 days

          -  Known allergy to HCQ or chloroquine

          -  Congenital prolonged QT syndrome

          -  Current or planned use of QT prolonging drugs (e.g. procainamide, disopyramide,
             mexiletine, flecainide, propafenone, amiodarone, sotalol, cimetidine, dronedarone,
             dofetilide, levofloxacin, ciprofloxacin, moxifloxacin) and other contraindicated
             medications

          -  End stage renal disease

          -  Pre-existing retinopathy

          -  Current or planned use of Hydroxychloroquine (study drug) for any indication

        Current or planned use of the following for treatment or prevention of COVID-19 infection:

          -  Chloroquine

          -  Azithromycin

               -  Known cirrhosis or severe liver disease

               -  History of severe skin reactions such as Steven-Johnson syndrome, toxic epidermal
                  necrolysis

               -  History of psoriasis or porphyria

               -  Ventricular arrhythmias requiring medical treatment

               -  Severe coronary artery disease or heart failure/cardiomyopathy with ongoing
                  symptoms

               -  Current or planned use of use of anti-seizure drugs

               -  History of Glucose-6-phosphate dehydrogenase deficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adrian Hernandez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rachel Olson, RN</last_name>
    <phone>919-668-5590</phone>
    <email>rachel.e.olson@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children's Hospital Colorado/University of Colorado Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Dempsey, MD</last_name>
      <email>amanda.dempsey@cuanschutz.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Merck, MD</last_name>
      <email>lmerck@ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nizar Maraqa, MD</last_name>
      <email>Nizar.maraqa@jax.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida Health Central Florida</name>
      <address>
        <city>Leesburg</city>
        <state>Florida</state>
        <zip>34748</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Berger, MD</last_name>
      <email>dberger@centflhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Miami Florida</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dushyantha Jayweera, MD</last_name>
      <email>DJayawee@med.miami.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advent Health</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Robinson, MD</last_name>
      <email>Patricia.Robinson@AdventHealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seetha Lakshmi, MD</last_name>
      <email>seetha@usf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faraz Ahmad, MD</last_name>
      <email>faraz.ahmad@northwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rush University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoona Rhee, MD</last_name>
      <email>yoona_rhee@rush.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loreen Herwaldt, MD</last_name>
      <email>loreen-herwaldt@uiowa.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mario Castro, MD</last_name>
      <email>mcastro2@kumc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center New Orleans</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jyotsna Fuloria, MD</last_name>
      <email>jyotsna.fuloria@lcmchealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Castex, MD</last_name>
      <email>jcastex@ochsner.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Sulkowski, MD</last_name>
      <email>msulkowski@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Higgins, MD</last_name>
      <email>phiggins@umich.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allina Health</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Rahme, MD</last_name>
      <email>frankrhame@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Hospital Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hassan Murad, MD</last_name>
      <email>Murad.Mohammad@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Missouri-Columbia</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Syed Hasan Naqvi, MD</last_name>
      <email>naqvis@health.missouri.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James McClay, MD</last_name>
      <email>jmcclay@unmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Stein</last_name>
      <email>steine@hss.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University, Irving Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Theodore, MD</last_name>
      <email>dat2132@cumc.columbia.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy Wilkin, MD MPH</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ross Boyce, MD</last_name>
      <email>ross_boyce@med.unc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deverick Anderson, MD</last_name>
      <email>deverick.anderson@duke.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caryn Morse, MD</last_name>
      <email>cmorse@wakehealth.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Southerland, MD</last_name>
      <email>lauren.southerland@osumc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nina Gentile, MD</last_name>
      <email>ngentile@temple.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh School of Medicine</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alison Morris, MD</last_name>
      <email>morrisa@upmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Trials Center of Middle Tennessee</name>
      <address>
        <city>Franklin</city>
        <state>Tennessee</state>
        <zip>37067</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aaron Milstone, MD</last_name>
      <email>amilstone@wmed.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sean Collins, MD</last_name>
      <email>sean.collins@vumc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Trish Pearl, MD</last_name>
      <email>trish.perl@utsouthwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White Medical Center-Temple</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lizbeth Cahuayme-Zuniga, MD</last_name>
      <email>Lizbeth.CahuaymeZuniga@bswhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle Zerr, MD</last_name>
      <email>danielle.zerr@seattlechildrens.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic Health System</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Haws, MD</last_name>
      <email>haws.robert@marshfieldclinic.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>April 2, 2020</study_first_submitted>
  <study_first_submitted_qc>April 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2020</study_first_posted>
  <last_update_submitted>August 24, 2020</last_update_submitted>
  <last_update_submitted_qc>August 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Duke University</investigator_affiliation>
    <investigator_full_name>Adrian Hernandez</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Hydroxychloroquine</keyword>
  <keyword>Coronavirus Infections</keyword>
  <keyword>Novel Coronavirus</keyword>
  <keyword>Protective agents</keyword>
  <keyword>Prophylaxis</keyword>
  <keyword>Chemoprophylaxis</keyword>
  <keyword>Severe Acute Respiratory Syndrome</keyword>
  <keyword>Respiratory Distress Syndrome, Adult</keyword>
  <keyword>Acute Lung Injury</keyword>
  <keyword>Virus Diseases</keyword>
  <keyword>Lung Diseases</keyword>
  <keyword>Respiratory Tract Diseases</keyword>
  <keyword>Respiration Disorders</keyword>
  <keyword>Lung Injury</keyword>
  <keyword>Coronaviridae Infections</keyword>
  <keyword>Nidovirales Infections</keyword>
  <keyword>RNA Virus Infections</keyword>
  <keyword>Respiratory Tract Infections</keyword>
  <keyword>Antimalarials</keyword>
  <keyword>Antiprotozoal Agents</keyword>
  <keyword>Antiparasitic Agents</keyword>
  <keyword>Anti-Infective Agents</keyword>
  <keyword>Enzyme Inhibitors</keyword>
  <keyword>Molecular Mechanisms of Pharmacological Action</keyword>
  <keyword>Antirheumatic Agents</keyword>
  <keyword>Chloroquine</keyword>
  <keyword>Chloroquine diphosphate</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxychloroquine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

